Suchergebnisse - "Weitz, Jeffrey I"

PubPharm (646)

1

Optimization of plasma-based BioID identifies plasminogen as a ligand of ADAMTS13

enthalten in: Scientific reports | 2024

von Madarati, H. | DeYoung, V. | Singh, K. | +8

2

Current Gaps in the Provision of Safe and Effective Anticoagulation in Atrial Fibrillation and the Potential for Factor XI-Directed Therapeutics

enthalten in: Critical pathways in cardiology | 2024

von Goodman, S. | Roy, D. | Pollack, C. | +9

3

Direct Oral Anticoagulation Versus Warfarin in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves : a Retrospective, Real-World Cohort Study

enthalten in: Cardiovascular drugs and therapy | 2024

von Eikelboom, R. | Whitlock, R. | Sibilio, S. | +4

4

Human platelets contain a pool of free zinc in dense granules

enthalten in: Research and practice in thrombosis and haemostasis | 2024

von Kahr, W. | Henderson, S. | Pluthero, F. | +5

5

Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis : a randomized phase 2 trial

enthalten in: Nature medicine | 2024

von Weitz, J. | Tankó, L. | Floege, J. | +8

6

Thrombin-activatable fibrinolysis inhibitor and sex modulate thrombus stability and pulmonary embolism burden in a murine model

enthalten in: Journal of thrombosis and haemostasis : JTH | 2024

von Chessum, J. | Shaya, S. | Rajab, D. | +5

7

When Direct Oral Anticoagulants Should Not Be Standard Treatment : JACC State-of-the-Art Review

enthalten in: Journal of the American College of Cardiology | 2024

von Bejjani, A. | Khairani, C. | Assi, A. | +24

ErratumIn: J Am Coll Cardiol. 2024 Apr 9;83(14):1351. - PMID 38569766

8

Study of Rivaroxaban for Cerebral Venous Thrombosis : A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis

enthalten in: Stroke | 2023

von Field, T. | Dizonno, V. | Almekhlafi, M. | +135

9

Warfarin faring better : vitamin K antagonists beat rivaroxaban and apixaban in the INVICTUS and PROACT Xa trials

enthalten in: Journal of thrombosis and haemostasis : JTH | 2023

von Eikelboom, J. | Weitz, J.

10

PAR4 Inhibition Reduces Coronary Artery Atherosclerosis and Myocardial Fibrosis in SR-B1/LDLR Double Knockout Mice

enthalten in: Arteriosclerosis, thrombosis, and vascular biology | 2023

von Lee, S. | Malik, R. | Zhou, J. | +5

CommentIn: Arterioscler Thromb Vasc Biol. 2023 Nov;43(11):2179-2182. - PMID 37767705

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[65]